Tirzepatide Microdose Injection

GLP-1 Microdosing. Weekly low-dose subcutaneous injection

Sub-therapeutic weekly dual GIP + GLP-1 dosing aimed at maintaining metabolic benefit with fewer side effects.

Dosing: Low-dose weekly injection, tuned by a HELiXVi clinician to the patient's response.

Best for: Maintenance-phase patients, side-effect sensitive patients, or those trialing a lower-dose dual-incretin protocol.

Key points

• Lower-dose tirzepatide approach
• Used for weight maintenance and reduced side-effect burden
• Clinician-supervised

Considerations

• Emerging protocol; ongoing clinical monitoring is required
• Prescription-only

Prescription treatment requires an online consultation with a licensed HELiXVi clinician. Individual results vary.

Start your free consultation right now

No clinic visit. Licensed US clinicians. Dispatched within 24 hours of your consultation and payment.

See the full weight loss program